Big Pharma’s Influence on ADHD Awareness: The Role of Educational Campaigns

Dr. Jerry Don Smith Jr.

In the vast landscape of healthcare, one of the key players is undeniably the pharmaceutical industry, commonly referred to as “big pharma.” This sector plays a pivotal role not only in the development and distribution of medications but also in shaping perceptions about various health conditions. One of the most intriguing cases of this influence is how the industry engages with Attention ...

Strategies of Big Pharma: Retaining Market Share and Profitability for ADHD Medications

Dr. Jerry Don Smith Jr.

·

The pharmaceutical industry plays a critical role in shaping how ADHD (Attention-Deficit/Hyperactivity Disorder) is perceived, diagnosed, and treated. As with any industry, the goal is not just to introduce a successful product but also to ensure its continued profitability. As popular ADHD medications lose their patent protections, pharmaceutical companies employ a v...

Direct-to-Consumer Advertising of ADHD Medications: Impacts on Diagnosis Rates and Public Perception

Dr. Jerry Don Smith Jr.

·

Introduction

In the realm of healthcare, few topics have been as hotly debated as the direct-to-consumer (DTC) advertising of prescription medications. DTC advertising is where pharmaceutical companies market prescription medications directly to the public, typically through mediums such as television, radio, print, and digital channels. One of the most controversial are...

The Rising Global Demand for ADHD Medications

Dr. Jerry Don Smith Jr.

·

Attention-Deficit/Hyperactivity Disorder (ADHD) is not an exclusively Western or American phenomenon. Although ADHD has been extensively studied and diagnosed in Western nations, particularly in the U.S., the recognition and diagnosis of this condition are on the rise globally. With this increased awareness comes a mounting demand for medications known to treat ADHD. But why is there a surge in the global app...

International Perceptions and Guidelines of ADHD: The Role of Big Pharma

Dr. Jerry Don Smith Jr.

·

Attention-Deficit/Hyperactivity Disorder (ADHD) is a well-documented and researched neurodevelopmental disorder with increasing prevalence rates across the globe. As with many medical conditions, its understanding, diagnosis, and treatment approaches vary by country and culture. Moreover, the pharmaceutical industry, often termed “Big Pharma,” plays a considerable role in shaping these guideli...

The Transformative Power of Integrative Medicine on Mental Health

Dr. Jerry Don Smith Jr.

·

As a practicing psychologist deeply entrenched in the world of mental health care, I’ve witnessed firsthand the transformative effects of integrated medicine on my clients. The journey towards healing is not a one-size-fits-all path, and incorporating elements of integrated medicine has proven to be a game-changer for many individuals struggling with their mental health.

A Personal Journe...

The Ethical Dilemma: Prescribing Stimulant Medications for Children with ADHD

Dr. Jerry Don Smith Jr.

·

In an era where the prescription of stimulant medications for Attention Deficit Hyperactivity Disorder (ADHD) is commonplace, a rising ethical debate has emerged regarding their use, especially in pediatric populations. This discourse revolves around the short-term and long-term implications of these medications, their potential overprescription, and the balance between potenti...

Equitable Access to ADHD Medications Worldwide: Barriers and Pathways

Dr. Jerry Don Smith Jr.

·

The global discourse on ADHD (Attention-Deficit/Hyperactivity Disorder) has surged in the past few decades, primarily due to increased awareness, research, and advocacy. However, access to ADHD medications, often considered the frontline treatment, varies substantially across the world. This inconsistency isn’t solely based on genuine medical disagreements but is intertwined with eco...